undamentalytics Newsletter
Sign in

Prokidney Corp. balance sheet

At the end of fiscal 2025, Prokidney Corp. had total assets of $336m, total liabilities of $34.8m and shareholders' equity of −$1.01bn. It held $109m in cash against $0 of debt: net cash of $109m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents490619910975
Total current assets505374396281190
Total assets518421441336249
Accounts payable35412
Total current liabilities1125363123
Total debt00000
Total liabilities1329393526
Shareholders' equity−1,097−1,103−995−1,011−884
Non-controlling interests and other (assets − liabilities − equity)1,6021,4951,3971,3121,106
Net debt (negative = net cash)−490−61−99−109−75

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: MNOV vs PROKPROK vs STTKLGVN vs PROK

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Prokidney Corp.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Prokidney Corp.